Insulet had 15 patents in internet of things during Q1 2024. Insulet Corp’s patents in Q1 2024 focus on improving insulin delivery algorithms by adjusting parameter settings based on sensor inputs, ensuring safety and accuracy in medicament delivery devices, modifying insulin delivery schedules based on user sensitivity, developing a rotary solenoid micro actuator for drug delivery, and implementing techniques to receive blood glucose measurements and adjust insulin delivery safety constraints accordingly. GlobalData’s report on Insulet gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Insulet Corp - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Insulet grant share with internet of things as a theme is 20% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Incorporation of additional sensors into adaptation of aid systems (Patent ID: US20240100253A1)

The patent filed by Insulet Corp. describes a system that utilizes generic sensor devices to adjust parameter settings of an insulin delivery algorithm based on sensor readings. The majority of these sensors provide readings that are not directly used as inputs to the drug delivery algorithm. The system includes a processor that evaluates sensor readings against baseline readings, calculates adjustments to parameter settings, and modifies medication dosages accordingly. The sensors can detect various user characteristics, and the processor can adjust multiple parameters based on sensor inputs, generating an adaptation parameter for the medication delivery algorithm.

The system involves a plurality of sensors generating outputs related to the user's state, a memory storing sensor baseline readings, and a processor executing programming instructions to adjust insulin delivery algorithm parameters based on sensor readings. The processor evaluates sensor readings against baseline readings, calculates preliminary parameter values, and adjusts insulin delivery parameters accordingly. The system can communicate wirelessly with sensors, store medication delivery algorithms, and utilize various sensors like fitness monitors, heart rate monitors, and blood glucose detectors. The wearable drug delivery device can receive external sensor signals, determine necessary parameter modifications, calculate adaptation parameters, and adjust medication delivery algorithm inputs based on sensor readings.

To know more about GlobalData’s detailed insights on Insulet, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.